109 related articles for article (PubMed ID: 7554039)
1. Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.
Schröder CP; van der Graaf WT; Kema IP; Groenewegen A; Sleijfer DT; de Vries EG
Cancer Chemother Pharmacol; 1995; 36(6):477-82. PubMed ID: 7554039
[TBL] [Abstract][Full Text] [Related]
2. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
3. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe B; Hallén C; Frankendal B
Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
[TBL] [Abstract][Full Text] [Related]
4. Prevention of emesis by tropisetron in children receiving combined chemotherapy with cisplatin.
Berberoglu S
Pediatr Hematol Oncol; 1995; 12(5):479-83. PubMed ID: 8519633
[TBL] [Abstract][Full Text] [Related]
5. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic investigation of 5-day multiple dose of tropisetron capsule in patients who had received cisplatin and the usefulness of tropisetron capsule in the treatment of nausea and vomiting].
Suminaga M; Akasaka Y; Nukariya N; Kimura A; Ohtawa M
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1209-21. PubMed ID: 7544965
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.
Albany C; Brames MJ; Fausel C; Johnson CS; Picus J; Einhorn LH
J Clin Oncol; 2012 Nov; 30(32):3998-4003. PubMed ID: 22915652
[TBL] [Abstract][Full Text] [Related]
9. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.
Sorbe B
Ann Oncol; 1993; 4 Suppl 3():39-42. PubMed ID: 8363999
[TBL] [Abstract][Full Text] [Related]
10. Prevention of emesis by ICS 205-930 in children receiving cytotoxic chemotherapy.
Hachimi-Idrissi S; De Schepper J; Maurus R; Otten J
Eur J Cancer; 1993; 29A(6):854-6. PubMed ID: 8484976
[TBL] [Abstract][Full Text] [Related]
11. On-demand antiemetic treatment with the serotonine antagonist tropisetron in cisplatin-treated cancer patients.
Havsteen H; Andersen LJ; Kjaer M; Dalmark M
Anticancer Drugs; 1994 Aug; 5(4):410-8. PubMed ID: 7949244
[TBL] [Abstract][Full Text] [Related]
12. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
[TBL] [Abstract][Full Text] [Related]
13. [Tropisetron hydrochloride in preventing and treating chemotherapy-induced nausea and vomiting: a phase II, randomized, multicenter, double-blinded, comparative clinical trial].
Zhang WD; Wang XW; Chen ZD; Qin FZ; Shu YQ; Pan LX; Zhang MH
Ai Zheng; 2007 Aug; 26(8):870-3. PubMed ID: 17697550
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron (ICS 205-930) in pediatric oncology: first results in patients refractory to antiemetic metoclopramide-based treatments.
Cefalo G; Rottoli L; Armiraglio A; Pagan MG
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):242-5. PubMed ID: 8037343
[TBL] [Abstract][Full Text] [Related]
15. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
16. [The antiemetic action of tropisetron (Navoban) in the cytostatic treatment of neoplastic diseases].
Buiuc AI; Găleşanu MR
Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):160-4. PubMed ID: 9455457
[TBL] [Abstract][Full Text] [Related]
17. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
18. The development of tropisetron in its clinical perspective.
de Bruijn KM
Ann Oncol; 1993; 4 Suppl 3():19-23. PubMed ID: 8363994
[TBL] [Abstract][Full Text] [Related]
19. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
20. Compassionate use of tropisetron in patients at high risk of severe emesis.
Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
Ann Oncol; 1993; 4 Suppl 3():43-5. PubMed ID: 8364000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
